Synthesis of ecteinascidin ET-743 and phthalascidin Pt-650 from cyanosafracin B

Organic Letters

Volumn 2, Issue 16, 2000, Pages 2545-2548

  Cuevas, Carmen ^a   Pérez, Marta ^a   Martín, María J ^a   Chicharro, Jose L ^a   Fernândez Rivas, Carolina ^a   Flores, María ^a   Francesch, Andrés ^a   Gallego, Pilar ^a   Zarzuelo, María ^a   De La Calle, Fernando ^a   García, Jesús ^a   Polanco, Concepción ^a   Rodríguez, Ignacio ^a   Manzanares, Ignacio ^a  

^a PHARMAMAR S A   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 DIOXOLANE DERIVATIVE; ALKYLATING AGENT; AZOCINE DERIVATIVE; CYANOSAFRACIN B; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; ISOQUINOLINE DERIVATIVE; PHTHALASCIDIN; PHTHALIMIDE DERIVATIVE; QUINONE DERIVATIVE; TETRAHYDROISOQUINOLINE DERIVATIVE; TRABECTEDIN;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; SYNTHESIS;

ANTINEOPLASTIC AGENTS, ALKYLATING; AZOCINES; DIOXOLES; INDICATORS AND REAGENTS; ISOQUINOLINES; MODELS, MOLECULAR; MOLECULAR CONFORMATION; PHTHALIMIDES; QUINONES; TETRAHYDROISOQUINOLINES;

EID: 0034632436     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol0062502     Document Type: Article

References (30)

1. (a) Rinehart, K. L.; Shield, L. S. Topics in Pharmaceutical Sciences; Breimer. D. D., Crommelin, D. J. A., Midha, K. K., Eds.; Amsterdam Medicinal Press: Noodwijk, The Netherlands, 1989; p 613.
2. (b) Rinehart, K. L.; Holt, T. G.; Fregeau, N. L.; Keifer, P. A.; Wilson, G. R.; Perun, T. J., Jr.; Sakai, R.; Thompson, A. G.; Sthroh, J. G.; Shield, L. S.; Seigler, D. S.; Li, L. H.; Martin, D. G.; Grimmelikhuijzen, C. J. P.; Gäde, G. J. J. Nat. Prod. 1990, 53, 771.
3. (c) Rinehart, K. L.; Sakai, R.; Holt, T. G.; Fregeau, N. L. Perun, T. J., Jr.; Seigler, D. S.; Wilson, G. R.; Shield, L. S. Pure Appl. Chem. 1990, 62, 1277.
4. (d) Rinehart, K. L.; Holt, T. G.; Fregeau, N. L.; Stroh, J. G.; Keifer, P. A.; Sun, F.; Li, H.; Martin, D. G. J. Org. Chem. 1990, 55, 4512.
5. (e) Wright, A. E.; Forleo, D. A.; Gunawardana, G. P.; Gunasekera, S. P.; Koehn, F. E.; McConnell, O. J. J. Org. Chem. 1990, 55, 4508.
6. (f) Sakai, R.; Rinehart, K. L.; Guan, Y.; Wang, H. J. Proc. Natl Acad. Sci. U.S.A. 1992, 89, 11456.
7. (g) Sakai, R.; Jares-Erijman, E.; Manzanares, I.; Elipe, M. V.; Rinehart, K. L. J. Am. Chem. Soc. 1996, 18, 9017.
8. (a) Zelek, L.; Yovine, A.; Etienne, B.; Jimeno, J.; Taamma, A.; Martín, C.; Spielmann, M.; Cvitkovic, E.; Misset, J. L. Ecteinacidin-743 in taxane /Antracycline pretreated advanced/ metastatic breast cancer patients: preliminary results with the 24 hour continous infusion Q3 week schedule, presented at the American Society of Clinical Oncology, 36th Annual Meeting, New Orleans, 20-23 May, 2000. Abstract number 592.
9. (b) Delaloge, S.; Yovine, A.; Taamma, A.; Cottu, P.; Riofrio, M.; Raymond, E.; Brain, E.; Marty, M.; Jimeno, J.; Cvitkovic, E.; Misset, J. L. Preliminary evidence of activity of Ecteinacidin-743 (ET-743) in heavily pretreated patients with bone and soft tissue sarcomas, presented at the American Society of Clinical Oncology, 36th Annual Meeting, New Orleans, 20-23 May, 2000. Abstract number 2181.
10. (c) Le Cesne, A.; Judson, I.; Blay, J. Y.; Radford, J.; an Oosterom, A.; Lorigan, P.; Rodenhuis, E.; Donato Di Paoula, E.; Van Glabbeke, M.; Jimeno, J.; Verweij, J. Phase II of ET-743 in advance soft tissue sarcoma in adult: a STBSG-EORTC trial, presented at the American Society of Clinical Oncology, 36th Annual Meeting, New Orleans, 20-23 May 2000. Abstract number 2182.
11. (a) Jin, S.; Gorfajn, B.; Faircloth, G.; Scotto, K. W. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 6775.
12. (b) Minuzzo, M.; Marchini, S.; Broggini, M.; Faircloth, G.; D'Incalci, M.; Mantovani, R. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 6780.
13. Corey, E. J.; Gin, D. Y.; Kania, R. J. Am. Chem. Soc. 1996, 118, 9202.
14. Martinez, E. J.; Owa, T.; Schreiber, S. L.; Corey, E. J. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 3496.
15. Martinez, E. J.; Corey, E. J. Org. Lett. 2000, 2, 993.
16. Tsuji Naoki, Japanese Patent JP 59225189, 1985.
17. Ikeda, Y.; Idemoto, H.; Hirayama, F.; Yamamoto, K.; Iwao, K.; Asao, T.; Munakata, T. J. Antibiot. 1983, 36, 1279.
18. General methods to cleave methyl ethers of quinone systems use Lewis acids or mineral acids, conditions not compatible with BOC and MOM groups. See, for example: Hoire, T.; Kobayashi, T.; Kawamura, Y.; Yoshida, I.; Tominaga, H.; Yamashita, K. Bull. Chem. Soc. Jpn. 1995, 65, 2033.
19. (a) Castillo, P.; Rodríguez-Ubis, J. C. Synthesis 1986, 839.
20. (b) Zelle, R. E.; McClellan, W. J. Tetrahedron Lett. 1991, 32, 2461.
21. Edman, P. Acta Chim. Scand. 1956, 10, 761, and references cited herein.
22. (a) Wiberg, K. B.; österle. C. G. J. Org. Chem. 1999, 64, 7756.
23. (b) Wiberg, K. B.; österle, C. G. J. Org. Chem. 1999, 64, 7763.
24. (c) Wiberg, K. B.; Shobe, D. S. J. Org. Chem. 1999, 64, 7768.
25. The TROC protecting group is compatible with the existing allyl and MOM groups.
26. For synthetic methods of imide derivatives, see: (a) Walker, M. A. J. Org. Chem. 1995, 60, 5352; Tetrahedron Lett. 1994, 35, 665.
27. For synthetic methods of imide derivatives, see: (a) Walker, M. A. J. Org. Chem. 1995, 60, 5352; Tetrahedron Lett. 1994, 35, 665.
28. (b) Corrie, J. E. T. J. Chem. Soc., Perkin Trans. 1 1994, 2975.
29. (c) Gill, G. B.; James, G. D.; Oates, K. V.; Pattenden, G. J. Chem. Soc., Perkin Trans. 1 1993, 2567.
30. (d) Braish, T. F.; Fox, D. E. Synlett 1992, 979.